A real estate investment trust based in San Diego , Innovative Industrial Properties, went public on the New York Stock Exchange last December to buy buildings and lease them to growers of medical marijuana. Cannabis-related companies also trade on the NASDAQ , but many are penny stocks and trade over the counter, where volatility is high and the risks are greater. Many OTC shares are not required to file audited financial reports with regulators, making it tougher for investors to get accurate and up-to-date financial information. Investments in pharmaceutical companies developing drugs from cannabis to treat ailments such as epilepsy and multiple sclerosis may be a natural fit for some investors in San Diego, where the biotech industry has a high profile. Medical marijuana Its no difference, Scatizzi said. You either believe the FDA is going to approve the drug or not. You either believe the drug is going to work or not. If it works, Merck, Pfizer, Bayer, will buy them. End of story. Theres going to be a huge value in it. It just happens that theyre getting their medication from cannabis. Investor networks are another avenue.
To read more visit http://www.orlandosentinel.com/sd-fi-cannabis-investing-20170306-story.html